Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cf2caf35a4f97a4534d8923f7fd25a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e92486a18c3b63862a9192e6aed7cdd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dd09cb546809ed59d24bab690e88a1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e62ed8f7404c52d8d56d088520d0106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_404f4658a9dc40bde6b45c97240cea81 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f832b01c5a72b760b13c13b3f8a3fbdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2464fcff9d0a91ce58c3942fc7421a23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b19e20caceeba3fc57feff2af6213ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afc548843409fd63b2a52488f6fe3e7 |
publicationDate |
2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9110063-B2 |
titleOfInvention |
Assay methods for the determination of FKBPL expression level in the context of breast cancer |
abstract |
Disclosed are methods that employ FKBPL as a marker for a subject's sensitivity to endocrine therapies in the treatment of cancers, and as a predictive marker of cancer progression and disease free survival in relation to hormone responsive cancers. |
priorityDate |
2009-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |